RxDoctor Payments Data

Leslie Miller, MD

Family Medicine · Fairfield, CTNPI 1225241359

Payments from drug & device makers

$779in general payments, 2019–2025

Across 36 payments — averaging $21.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$221
  • Novo Nordisk$195
  • GSK$147
  • Amgen$121
  • Exact Sciences$25
  • Sanofi-aventis U.S. LLC$21
  • plus $48 from 3 others

What the payments were for

  • Food & beverage$65884%
  • Education$12116%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$779 in reported general payments places this provider in the 65th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$43,704
Medicare patients
70
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SymbicortBudesonide/Formoterol Fumarate11$2,636
Candesartan Cilexetil33$2,539
Rosuvastatin Calcium179$2,242
Ezetimibe88$1,911
Risedronate Sodium15$1,512
Valsartan90$1,253
Levothyroxine Sodium101$762
Metoprolol Succinate59$712
Omeprazole37$660
Desvenlafaxine Succinate ErDesvenlafaxine Succinate13$541
Amlodipine Besylate79$530
Pravastatin Sodium20$522
Atorvastatin Calcium71$339
Escitalopram Oxalate26$312
Atenolol20$249

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaSymbicort$15$2,63611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 588 family medicine providers in Connecticut.

Other family medicine in Fairfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →